CRISPR-Cas knockout of miR21 reduces glioma growth.
Nieland L, van Solinge TS, Cheah PS, Morsett LM, El Khoury J, Rissman JI, Kleinstiver BP, Broekman MLD, Breakefield XO, Abels ER.
Nieland L, et al.
Mol Ther Oncolytics. 2022 Apr 6;25:121-136. doi: 10.1016/j.omto.2022.04.001. eCollection 2022 Jun 16.
Mol Ther Oncolytics. 2022.
PMID: 35572197
Free PMC article.